rs9277535 — HLA-DPB1

HLA-DPB1 rs9277535 — The Antigen Presentation Rheostat

HLA-DPB1 encodes the beta chain of the HLA-DP molecule, a class II MHC receptor that presents peptide antigens to CD4+ T helper cells. This is the essential handshake that triggers adaptive immunity: without robust HLA-DP surface expression, the immune system cannot efficiently recognize viral peptides and mount a clearance response. The rs9277535 variant sits in the [3' untranslated region (3' UTR) | The regulatory sequence at the end of the mRNA transcript that controls stability, translation efficiency, and expression level — not the protein-coding region itself] of HLA-DPB1 and acts as an [eQTL | expression quantitative trait locus — a variant whose primary effect is on how much gene product is made rather than what kind] controlling transcript levels. The G allele substantially reduces HLA-DPB1 mRNA, shifting the antigen presentation dial downward.

The Mechanism

The rs9277535 G allele lies in the 3' UTR of HLA-DPB1 transcript NM_002121.6 and is in [linkage disequilibrium | Alleles at nearby positions that tend to be inherited together more often than expected by chance, so rs9277535 G tags a broader haplotype block] with functionally connected variants across the HLA-DP locus. Expression studies confirmed that the GG genotype is associated with the lowest HLA-DPB1 mRNA levels¹¹ GG genotype is associated with the lowest HLA-DPB1 mRNA levels
p=10⁻¹⁵ in 651 normal liver samples; allelic expression imbalance analysis in 17–19 heterozygotes confirmed the G allele produces less transcript than the A allele across liver tissue. Lower surface HLA-DPB1 expression translates directly to fewer antigen-presenting molecules available to engage virus-derived peptides and activate CD4+ T helper cells.

The consequence is a classic MHC trade-off: reduced HLA-DPB1 expression limits the risk of excessive immune activation (relevant to autoimmune conditions), but also limits the immune system's capacity to clear intracellular pathogens that depend on CD4+ T helper responses for viral elimination. This tension explains why rs9277535 simultaneously influences risk in opposite directions for viral infections and certain autoimmune diseases.

The Evidence

Hepatitis B clearance provides the most robustly replicated phenotype. A study of 200 Taiwanese chronic HBV patients compared those who spontaneously [cleared HBsAg | Hepatitis B surface antigen — its disappearance from blood marks functional cure of chronic infection] against persistent carriers, finding the non-GG genotype enriched in the clearance group (57% vs 42%; OR 1.83, P=0.034)²² non-GG genotype enriched in the clearance group (57% vs 42%; OR 1.83, P=0.034)
Cheng et al. 2013, PLoS One; haplotype analysis combining rs3077 and rs9277535 strengthened the OR to 2.17. Replication in an Indonesian cohort of 686 participants confirmed a protective association across a South-East Asian population (OR 0.70 additive model, P=0.026)³³ (OR 0.70 additive model, P=0.026). The underlying molecular mechanism — reduced HLA-DPB1 expression in risk allele carriers — was mechanistically established in liver eQTL analysis, directly linking the expression deficit to the antigen presentation failure that allows HBV to persist (O'Brien et al. 2011, Genes & Immunity)⁴⁴ (O'Brien et al. 2011, Genes & Immunity).

Autoimmune disease associations reveal the other side of the trade-off. In multiple sclerosis, rs9277535 shows an independent genome-wide significant association with susceptibility (combined P=2×10⁻¹⁰ across 3,830 MS cases and 5,664 controls)⁵⁵ (combined P=2×10⁻¹⁰ across 3,830 MS cases and 5,664 controls) driven by the correlation with HLA-DPB1*03:01 — a specific protein allotype linked to MS in earlier candidate-gene studies. For rheumatoid arthritis, the picture reflects the expression axis clearly: in Chinese Han patients, the A allele (higher HLA-DPB1 expression) was associated with increased RA susceptibility (OR 1.409, P=0.004; 254 RA cases, 391 controls)⁶⁶ (OR 1.409, P=0.004; 254 RA cases, 391 controls) and elevated anti-CCP antibodies, while the G allele (lower expression) was protective⁷⁷ G allele (lower expression) was protective
OR for protective effect confirmed in 805 RA patients vs 1,095 controls; AG and GG genotypes associated with lower plasma HLA-DPB1 levels. This inverse relationship — the same allele that reduces HBV clearance reduces RA risk — is the hallmark of [balancing selection | Evolutionary pressure maintaining both alleles in a population because heterozygotes have an advantage over either homozygote, common in MHC genes exposed to conflicting infectious and autoimmune pressures] at the MHC locus.

Practical Actions

The G allele's primary actionable consequence is impaired HBV clearance capacity. GG homozygotes have lower HLA-DPB1 surface expression, producing a weaker CD4+ T helper response to hepatitis B antigens. This translates to reduced natural clearance after HBV exposure and, importantly, reduced vaccine response — HBV vaccine efficacy depends on the same antigen presentation machinery this variant diminishes. AA individuals who carry two copies of the higher-expression A allele have efficient antigen presentation but carry elevated susceptibility to autoimmune conditions like RA in populations where this trade-off is clinically relevant.

The G allele is substantially more common in East Asian populations (~62% allele frequency vs ~24% in Europeans), which aligns with the higher burden of HBV chronic infection in East Asian countries and the known population-stratified effects of HLA-DP variants on HBV outcomes. Because G allele carriers may mount suboptimal vaccine responses, verifying seroconversion after HBV vaccination is a specific, genotype-informed recommendation.

Interactions

rs9277535 interacts with rs3077 (in the 3' UTR of the neighboring HLA-DPA1 gene) to form a combined HLA-DP haplotype. The GA haplotype (rs3077 G + rs9277535 A) showed a stronger association with HBV clearance than either SNP alone (OR 2.17 vs 1.83 for rs9277535 alone). The two SNPs co-regulate the HLA-DPA1/DPB1 heterodimer — the functional antigen presentation unit — meaning that variation in both alpha and beta chains together determines the overall antigen presentation phenotype. The nearby rs9277534 (496A/G) tags a different haplotype block with partially overlapping effects. For a comprehensive HLA-DP antigen presentation assessment, both rs3077 and rs9277535 should be interpreted together.